Alex Lu is an associate in the litigation department of Goodwin. She has worked on multiple Hatch-Waxman matters, matters relating to the Dormant Therapies Act and FDA regulatory matters. Ms. Lu is a contributor to the firm’s Big Molecule Watch blog which tracks developments in the biosimilars space.
While in law school, Ms. Lu was a student and student director in the Immigration Legal Services Clinic at Yale Law School. In addition, Ms. Lu was an editor for the Yale Law Journal and a lead editor for the Yale Law and Policy Review. She was a summer intern at the Department of Justice Civil Rights Division, Housing and Civil Enforcement Section.
Yale Law School
(magna cum laude; Phi Beta Kappa; John Harvard Scholar)